Total Payments
$551.42
2024 Payments
$47.96
Companies
9
Transactions
17
Medicare Patients
2,250
Medicare Billing
$310,602
Payment Breakdown by Category
Food & Beverage$305.23 (55.4%)
Education$246.19 (44.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $305.23 | 13 | 55.4% |
| Education | $246.19 | 4 | 44.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $220.98 | 3 | $0 (2018) |
| Celgene Corporation | $89.80 | 4 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $69.06 | 3 | $0 (2024) |
| ADC Therapeutics America, Inc. | $55.86 | 1 | $0 (2022) |
| Merck Sharp & Dohme LLC | $42.79 | 2 | $0 (2022) |
| Agios Pharmaceuticals, Inc. | $25.21 | 1 | $0 (2023) |
| AbbVie, Inc. | $17.74 | 1 | $0 (2019) |
| Clovis Oncology, Inc. | $16.13 | 1 | $0 (2019) |
| Pharmacyclics LLC, An AbbVie Company | $13.85 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $47.96 | 2 | AstraZeneca Pharmaceuticals LP ($47.96) |
| 2023 | $53.02 | 2 | Celgene Corporation ($27.81) |
| 2022 | $78.93 | 2 | ADC Therapeutics America, Inc. ($55.86) |
| 2019 | $75.16 | 4 | AstraZeneca Pharmaceuticals LP ($21.10) |
| 2018 | $160.99 | 2 | Janssen Biotech, Inc. ($160.99) |
| 2017 | $135.36 | 5 | Janssen Biotech, Inc. ($59.99) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/04/2024 | AstraZeneca Pharmaceuticals LP | EPANOVA (Drug) | Food and Beverage | In-kind items and services | $26.44 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/09/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: Oncology | ||||||
| 11/16/2023 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $27.81 | General |
| Category: Hematology | ||||||
| 01/06/2023 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Education | In-kind items and services | $25.21 | General |
| Category: Genetically Defined Disease | ||||||
| 11/10/2022 | ADC Therapeutics America, Inc. | — | Food and Beverage | Cash or cash equivalent | $55.86 | General |
| 05/09/2022 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: ONCOLOGY | ||||||
| 06/11/2019 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: Oncology | ||||||
| 04/03/2019 | Clovis Oncology, Inc. | Rubraca (Drug) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: Oncology | ||||||
| 03/20/2019 | AbbVie, Inc. | Venclexta (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Virology | ||||||
| 03/12/2019 | Celgene Corporation | Abraxane (Drug) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: Oncology | ||||||
| 09/27/2018 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Oncology | ||||||
| 05/08/2018 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Education | In-kind items and services | $61.99 | General |
| Category: Oncology | ||||||
| 12/13/2017 | Celgene Corporation | Abraxane (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: Oncology | ||||||
| 10/18/2017 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: Oncology | ||||||
| 10/04/2017 | Celgene Corporation | Idhifa (Drug) | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: Hematology | ||||||
| 08/08/2017 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Education | In-kind items and services | $59.99 | General |
| Category: Oncology | ||||||
| 04/26/2017 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 787 | 14,114 | $510,629 | $114,329 |
| 2022 | 12 | 430 | 1,539 | $236,392 | $62,651 |
| 2021 | 5 | 464 | 796 | $112,606 | $67,485 |
| 2020 | 5 | 569 | 1,172 | $129,965 | $66,137 |
Total Patients
2,250
Total Services
17,621
Medicare Billing
$310,602
Procedure Codes
43
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 189 | 344 | $137,600 | $30,403 | 22.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 100 | 137 | $47,128 | $10,271 | 21.8% |
| J1439 | Injection, ferric carboxymaltose, 1 mg | Office | 2023 | 11 | 11,250 | $56,250 | $9,739 | 17.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 34 | 67 | $30,150 | $9,532 | 31.6% |
| 96522 | Refilling and maintenance of implantable pump or reservoir for drug delivery | Office | 2023 | 28 | 99 | $39,600 | $8,897 | 22.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 41 | 77 | $35,497 | $8,859 | 25.0% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 15 | 67 | $35,175 | $7,189 | 20.4% |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | Office | 2023 | 15 | 910 | $18,200 | $5,631 | 30.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 40 | 81 | $24,300 | $5,382 | 22.1% |
| 96361 | Infusion into a vein for hydration, each additional hour | Office | 2023 | 38 | 446 | $22,300 | $4,489 | 20.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 28 | 28 | $14,392 | $2,871 | 19.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 27 | 47 | $9,400 | $2,174 | 23.1% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 20 | 42 | $9,450 | $2,040 | 21.6% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 23 | 81 | $8,100 | $1,822 | 22.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 47 | 127 | $6,350 | $1,282 | 20.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 22 | 23 | $5,428 | $1,166 | 21.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 16 | 16 | $5,504 | $994.65 | 18.1% |
| 96360 | Infusion into a vein for hydration, 31-60 minutes | Office | 2023 | 14 | 28 | $2,800 | $742.69 | 26.5% |
| 99415 | Extended office or other outpatient service by clinical staff, first hour | Office | 2023 | 20 | 41 | $1,845 | $644.52 | 34.9% |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | Office | 2023 | 37 | 145 | $1,015 | $149.67 | 14.7% |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | Office | 2023 | 22 | 58 | $145.00 | $52.51 | 36.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 223 | 382 | $152,800 | $40,267 | 26.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 24 | 36 | $16,200 | $5,193 | 32.1% |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | Office | 2022 | 12 | 690 | $13,800 | $4,433 | 32.1% |
| 96522 | Refilling and maintenance of implantable pump or reservoir for drug delivery | Office | 2022 | 17 | 34 | $13,600 | $3,518 | 25.9% |
About Dr. Nancy Morin, MD
Dr. Nancy Morin, MD is a Hematology & Oncology healthcare provider based in Wakefield, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1992765713.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nancy Morin, MD has received a total of $551.42 in payments from pharmaceutical and medical device companies, with $47.96 received in 2024. These payments were reported across 17 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($305.23).
As a Medicare-enrolled provider, Morin has provided services to 2,250 Medicare beneficiaries, totaling 17,621 services with total Medicare billing of $310,602. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Hematology & Oncology
- Location Wakefield, RI
- Active Since 03/24/2006
- Last Updated 10/16/2025
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1992765713
Products in Payments
- IMBRUVICA (Drug) $220.98
- KEYTRUDA (Biological) $42.79
- TAGRISSO (Drug) $42.62
- Abraxane (Drug) $37.40
- REBLOZYL (Biological) $27.81
- EPANOVA (Drug) $26.44
- PYRUKYND (Drug) $25.21
- Idhifa (Drug) $24.59
- Venclexta (Drug) $17.74
- Rubraca (Drug) $16.13
- Imbruvica (Drug) $13.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Wakefield
Dr. Gerald Colvin, Do, DO
Hematology & Oncology — Payments: $280,772
Hematology & Oncology $280,772
Dr. James Smythe, Md, MD
Hematology & Oncology — Payments: $1,907
Hematology & Oncology $1,907
Sylvia Alarcon Velasco, M.d, M.D
Hematology & Oncology — Payments: $906.29
Hematology & Oncology $906.29
Dr. Jean Lee, Md, MD
Hematology & Oncology — Payments: $218.38
Hematology & Oncology $218.38